Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features-Reference-Cited by-同舟云学术

Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features

Published:1994 Issue:3 Volume:29 Page:237-245
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

L�nn Ulf,L�nn Sigrid,Nilsson Bo,Stenkvist Bj�rn

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00666477.pdf

Reference35 articles.

1. Stenkvist B, Bengtsson E, Dahlqvist B, Eklund G, Eriksson O, Jarkrans T, Nordin B: Predicting breast cancer recurrence. Cancer 50: 2882?2893, 1982

2. Ponten J, Holmberg L, Trichopoulus D, Kallioniemi O-P, Kv�le G, Wallgren A, Taylor-Papadimitriou J: Biology and natural history of breast cancer. Int J Cancer Suppl 5: 5?21, 1990

3. Perren TJ: c-erb-B2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63: 328?332, 1991

4. Van de Vijver M, Peterse J, Mooi W, Wisman P, Lomans J, Dalesio O, Nusse R: Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinomain situ and limited prognostic value in Stage II breast cancer. N Engl J Med 319: 1239?1245, 1988

5. Lammie A, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3: 413?420, 1991

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients;World Journal of Surgical Oncology;2011-02-06

2. Predicting distant dissemination in patients with early breast cancer;Acta Oncologica;2008-01

3. Twenty-five years of follow-up in patients with operable breast carcinoma;Cancer;2006

4. Time-dependent effects on survival in breast carcinoma;Cancer;2004-02-23

5. Valoración inmunohistoquímica de la expresión de c-erb B2 como variable independiente en el carcinoma mamario T2N1 patológico;Cirugía Española;2001-01